Trial Profile
A study of HSRx431 for the treatment of Zika virus
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs HSRx 431 (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- 23 Sep 2016 New trial record
- 06 Sep 2016 According to a HSRx Biopharmaceutical media release, this trial anticipated in the early 2017.